Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 157-163 , February 2010

Plasma ACE2 Activity is an Independent Prognostic Marker in Chagas' Disease and Equally Potent as BNP

  • Yong Wang, PhD

      Affiliations

    • Centre for Biomedical Research, Hull York Medical School, University of Hull, Hull, UK
    • Both authors contributed equally to this work.
    • ,
  • Maria da Consolação V. Moreira, MD, PhD

      Affiliations

    • Department of Internal Medicine, UFMG, Belo Horizonte, Brazil
    • Both authors contributed equally to this work.
    • ,
  • Silvia Heringer-Walther, MD, PhD

      Affiliations

    • Department of Obstetrics, University of Leipzig, Leipzig, Germany
    • ,
  • Linda Ebermann, MSc

      Affiliations

    • Department of Cardiology, Charité, Campus Benjamin Franklin, Berlin, Germany
    • ,
  • Heinz-Peter Schultheiss, MD

      Affiliations

    • Department of Cardiology, Charité, Campus Benjamin Franklin, Berlin, Germany
    • ,
  • Niels Wessel, PhD

      Affiliations

    • Department of Physics, Humboldt Universität zu Berlin, Berlin, Germany
    • ,
  • Wolf-Eberhard Siems, PhD

      Affiliations

    • Leibniz-Institute of Molecular Pharmacology, Berlin, Germany
    • ,
  • Thomas Walther, PhD

      Affiliations

    • Centre for Biomedical Research, Hull York Medical School, University of Hull, Hull, UK
    • Excellence Cluster Cardio-Pulmonary System, Justus-Liebig-Universität Giessen, Germany
    • Corresponding Author InformationReprint requests: Prof. Thomas Walther, Centre for Biomedical Research, Hull York Medical School, University of Hull, Hull, HU6 7RX, UK. Tel: (+44) 1482-46 5513; Fax: (+44) 1482-46 5008.

Received 6 July 2009 ,Revised 15 September 2009 ,Accepted 23 September 2009.

References 

  1. Chagas' disease—an epidemic that can no longer be ignored. Lancet. 2006;368:619
  2. Higuchi Mde L, Benvenuti LA, Martins Reis M, Metzger M. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res. 2003;60:96–107
  3. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105:2392–2397
  4. Price JF, Thomas AK, Grenier M, Eidem BW, O'Brian Smith E, Denfield SW, et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation. 2006;114:1063–1069
  5. Walther T, Heringer-Walther S, Wessel N, Schultheiss HP, Moreira Mda C. Brain natriuretic peptide as a predictor of cardiomyopathy in Chagas' disease. Lancet. 2003;361:1567
  6. Heringer-Walther S, Moreira MC, Wessel N, Saliba JL, Silvia-Barra J, Pena JL, et al. Brain natriuretic peptide predicts survival in Chagas' disease more effectively than atrial natriuretic peptide. Heart. 2005;91:385–387
  7. Melo RB, Parente GB, Victor EG. Measurement of human brain natriuretic peptide in patients with Chagas' disease. Arq Bras Cardiol. 2005;84:137–140
  8. Moreira Mda C, Heringer-Walther S, Wessel N, Moreira Ventura T, Wang Y, Schultheiss HP, et al. Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation. Cardiology. 2008;110:217–225
  9. Heringer-Walther S, Moreira Mda C, Wessel N, Wang Y, Ventura TM, Schultheiss HP, et al. Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies?. J Cardiovasc Pharmacol. 2006;48:293–298
  10. Le TH, Coffman TM. Targeting genes in the renin-angiotensin system. Curr Opin Nephrol Hypertens. 2008;17:57–63
  11. Dzau VJ. Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 2001;37:1047–1052
  12. Raizada MK, Ferreira AJ. ACE2: a new target for cardiovascular disease therapeutics. J Cardiovasc Pharmacol. 2007;50:112–119
  13. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A. 2003;100:8258–8263
  14. Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532:107–110
  15. Gembardt F, Sterner-Kock A, Imboden H, Spalteholz M, Reibitz F, Schultheiss HP, et al. Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides. 2005;26:1270–1277
  16. Epelman S, Tang WH, Chen SY, Van Lente F, Francis GS, Sen S. Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J Am Coll Cardiol. 2008;52:750–754
  17. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002;277:14838–14843
  18. Huang L, Sexton DJ, Skogerson K, Devlin M, Smith R, Sanyal I, et al. Novel peptide inhibitors of angiotensin-converting enzyme 2. J Biol Chem. 2003;278:15532–15540
  19. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154–e235
  20. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115–1140
  21. Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI, et al. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem. 2005;280:30113–30119
  22. Boehm M, Nabel EG. Angiotensin-converting enzyme 2—a new cardiac regulator. N Engl J Med. 2002;347:1795–1797
  23. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87:E1–E9
  24. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822–828
  25. Gurley SB, Allred A, Le TH, Griffiths R, Mao L, Philip N, et al. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest. 2006;116:2218–2225
  26. Yamamoto K, Ohishi M, Katsuya T, Ito N, Ikushima M, Kaibe M, et al. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension. 2006;47:718–726
  27. Loot AE, Roks AJ, Henning RH, Tio RA, Suurmeijer AJ, Boomsma F, et al. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation. 2002;105:1548–1550
  28. Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, et al. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res. 2008;103:1319–1326
  29. Goulter AB, Goddard MJ, Allen JC, Clark KL. ACE2 gene expression is up-regulated in the human failing heart. BMC Med. 2004;2:19
  30. Greenberg B. An ACE in the hole alternative pathways of the renin angiotensin system and their potential role in cardiac remodeling. J Am Coll Cardiol. 2008;52:755–757

 Supported by a DAAD and CAPES grant (415-br-probral/po-D/08/11632).

 Conflict of interests: None.

PII: S1071-9164(09)01089-6

doi: 10.1016/j.cardfail.2009.09.005

Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 157-163 , February 2010

Article Tools

* Image Usage & Resolution